Latest news
Moleculin Biotech updates Annamycin data, prices stock offering at $0.75 - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sat, 01 Aug 2026 06:43:05 GMTFibroBiologics Doses First Patients in CYWC628 Phase 1/2 Trial for Diabetic Foot Ulcers - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sat, 01 Aug 2026 06:38:05 GMTFibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate - SahmSahm · Fri, 31 Jul 2026 07:00:00 GMTFibroBiologics Starts Human Testing for Diabetic Foot Ulcers - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMT